A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma
Titel:
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma
Auteur:
Leonard, J.P. Friedberg, J.W. Younes, A. Fisher, D. Gordon, L.I. Moore, J. Czuczman, M. Miller, T. Stiff, P. Cheson, B.D. Forero-Torres, A. Chieffo, N. McKinney, B. Finucane, D. Molina, A.